Wird geladen...
A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report
Capecitabine is an oral fluoropyrimidine which can prolong QT interval. However, there have been no reports that capecitabine induced ventricular fibrillation (VF) due to secondary QT prolongation in patients with no structural heart disease. A 39-year-old woman developed VF during the chemotherapy...
Gespeichert in:
| Veröffentlicht in: | J Cardiol Cases |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Japanese College of Cardiology
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6149258/ https://ncbi.nlm.nih.gov/pubmed/30279790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2017.03.009 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|